An observational study reports that human subjects harboring loss-of-function ANGPTL3 mutations show decreased serum ANGPTL3 protein levels, as well as decreased TG, LDL-cholesterol, and HDL-cholesterol, as well as lower incidence of coronary artery disease [12]. Here, ANGPTL3 is linked to coronary artery disorder.